Leerink Partners Downgrades CONMED (CNMD) to Market Perform

July 28, 2016 7:17 AM

Leerink Partners downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $47.00 (from $56.00).Analyst Richard ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found